183 related articles for article (PubMed ID: 14747791)
1. Glycemic status in hyperthyroid subjects.
Paul DT; Mollah FH; Alam MK; Fariduddin M; Azad K; Arslan MI
Mymensingh Med J; 2004 Jan; 13(1):71-5. PubMed ID: 14747791
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
Díez JJ
Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
[TBL] [Abstract][Full Text] [Related]
3. Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma.
Lantz M; Abraham-Nordling M; Svensson J; Wallin G; Hallengren B
Eur J Endocrinol; 2009 Feb; 160(2):201-6. PubMed ID: 19004985
[TBL] [Abstract][Full Text] [Related]
4. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
[TBL] [Abstract][Full Text] [Related]
5. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
[TBL] [Abstract][Full Text] [Related]
6. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
7. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study.
Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK
Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of 110 Ethiopians with thyrotoxicosis.
Mengistu M
East Afr Med J; 1992 Sep; 69(9):515-9. PubMed ID: 1286635
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokines levels in Graves' disease.
Al-Humaidi MA
Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
[TBL] [Abstract][Full Text] [Related]
10. A Pediatric Case of Graves' Hyperthyroidism with Associated Glucose Intolerance Detected by a Urine Glucose Screening Program at School.
Ikegami T; Yamamoto Y; Goto M; Kawagoe R; Kawada Y; Kusuhara K
J UOEH; 2018; 40(3):231-236. PubMed ID: 30224619
[TBL] [Abstract][Full Text] [Related]
11. HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves' hyperthyroidism.
Yang L; Shen X; Yan S; Yuan X; Lu J; Wei W
Diabetes Res Clin Pract; 2013 Jul; 101(1):28-34. PubMed ID: 23684448
[TBL] [Abstract][Full Text] [Related]
12. [Thyrotoxicosis at the onset of diabetes mellitus. Report of five cases].
Duun EH; Nygaard B; Nerup J
Ugeskr Laeger; 1998 Jul; 160(29):4327-30. PubMed ID: 9679440
[TBL] [Abstract][Full Text] [Related]
13. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
[TBL] [Abstract][Full Text] [Related]
14. [Hyperthyroidism and carcinoma of the thyroid gland].
Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of hyperthyroidism.
Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital.
S SY; Padma S; Sundaram PS
Ann Nucl Med; 2024 Mar; 38(3):231-237. PubMed ID: 38277114
[TBL] [Abstract][Full Text] [Related]
20. Thyroid uptake of radioactive iodine in hyperthyroidism.
Hooper PL; Caplan RH
JAMA; 1977 Aug; 238(5):411-3. PubMed ID: 577556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
